Ginkgo Bioworks Holdings, Inc.’s DNA share price has surged by 14.49%, which has investors questioning if this is right time ...
Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the ...
Ginkgo Bioworks Holdings, Inc.’s DNA share price has dipped by 16.38%, which has investors questioning if this is right time to buy.
Ginkgo Bioworks (DNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...
Boston, MA – Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) recently reported a stock transaction by its Chief Financial Officer, Mark E. Dmytruk, according to a recent SEC filing. The transaction comes as ...
马萨诸塞州波士顿 - 根据最近的SEC文件显示,Ginkgo Bioworks Holdings, Inc. (NYSE: DNA )的首席财务官Mark E. Dmytruk进行了一次股票交易。在公司股票年初至今上涨66.6%的强劲势头下进行了此次交易。根据 InvestingPro ...